{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/379437645"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Data on types of treatment, efficacy and adverse events were obtained from MEDLINE, the Cochrane database and abstracts from national meetings.Population:Six randomized, controlled trials with a total of 1,756 patients.Main Results:Sustained virologic response was greater for patients treated with pegylated interferon + ribavirin compared with patients treated with interferon + ribavirin or pegyla" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "thebody.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/14407848"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/379437645"] } } }
